DSM-Firmenich AG (ENXTAM: DSFIR)
Materials · Chemicals · CH
€108.80
+0.88% today · +43.8% 1Y
DSM-Firmenich AG (ENXTAM: DSFIR) operates in the Chemicals industry within the Materials sector. The company is valued at $30.11B and employs 28,550 people.
Over the last twelve months the share price has gained 43.8%, trading between 55.22 and 109.85.
Tweenvest scores DSM-Firmenich AG across four factors: quality 70/100, value 29/100, growth 30/100, dividend 45/100. Its strongest factor is quality.
DSFIR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.11B
- Revenue (TTM)
- $10.35B
- P/E
- 85.01
- EPS
- -5.56
- Dividend yield
- 2.32%
- Beta (5Y)
- 0.53
- 52-week high
- €109.85
- 52-week low
- €55.22
- Avg volume (3M)
- —
- Shares outstanding
- 247.01M
- Employees
- 28,550
- Next earnings
- —
About DSM-Firmenich AG
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
- ISIN
- CH1216478797
- Founded
- 1902
- Listed since
- May 9, 2023
- Exchange
- Euronext Amsterdam
- Currency
- EUR
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Saudi Basic Industries CorporationSASE: 2010 | $35.62B | SR44.56 | -2.71% |
| Novozymes A/SCPSE: NSIS B | $33.44B | Dkr479.00 | +2.66% |
| Nutrien Ltd.TSX: NTR | $32.88B | CA$96.70 | +1.10% |
| Wanhua Chemical Group Co., Ltd.SHSE: 600309 | $30.88B | CN¥65.86 | -0.93% |
| PPG Industries, Inc.NYSE: PPG | $25.14B | $113.09 | +2.65% |
| EMS-CHEMIE HOLDING AGSWX: EMSN | $25.09B | CHF883.50 | -1.34% |
| Ningxia Baofeng Energy Group Co., Ltd.SHSE: 600989 | $24.35B | CN¥22.40 | -3.66% |
| International Flavors & Fragrances Inc.NYSE: IFF | $23.94B | $93.83 | +3.08% |
Figures last refreshed Oct 18, 2026.